Charles River Laboratories International CRL
NYSE CRL
$304.73 +5.71 (+1.91%)
As of: Oct 14, 2026 · 12:42 PM EDT

Charles River Laboratories International (CRL) Interest & Investment Income (2009 - 2026)

Updated

Charles River Laboratories International's Interest & Investment Income came in at $1.03 million for Q2 2026, down 5.9% from $1.1 million a year earlier and down 0.1% from the prior quarter.

Analysis

Charles River Laboratories International (CRL) Interest & Investment Income (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 27, 2026, Charles River Laboratories International reported Interest & Investment Income of $4.5 million, down 23.2% year-over-year; for FY2025, it was $4.94 million, down 42.4% from FY2024.

  • Interest & Investment Income carries a five-year compound annual growth rate of 42.7% (FY2020 to FY2025).
  • Going back by year, Interest & Investment Income was $8.58 million in FY2024 (+65.0%), $5.2 million in FY2023 (+566.2%), $780,000 in FY2022 (+19.6%) and $652,000 in FY2021 (-21.8%).
  • The five-year range for quarterly Interest & Investment Income is $122,000 (Q3 2022) to $3.01 million (Q2 2024).
  • Year-over-year, Interest & Investment Income has declined for six consecutive quarters, with an average decline of 19.6% over the last eight quarters.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q2 2023 (growth of 658.5%), and the weakest in Q2 2025 (a decline of 63.6%).
  • Business Quant data shows CRL's Interest & Investment Income at $1.03 million (Q1 2026), $1.02 million (Q4 2025) and $1.42 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Iqvia Holdings 43.66 Bn 35.37 Bn 1.44 Bn 7.00 Mn
2 Medpace Holdings 17.37 Bn 15.43 Bn 201.64 Mn -
3 Charles River Laboratories International 14.62 Bn 13.81 Bn 363.37 Mn 1.03 Mn
4 Icon 13.27 Bn 10.38 Bn 479.29 Mn 3.16 Mn
5 Fortrea Holdings 2.05 Bn 1.42 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 732.40 Mn -29.68 Mn 18.44 Mn -
7 Evotec SE 507.87 Mn -1.10 Bn - -
8 Champions Oncology 67.26 Mn 42.35 Mn 7.70 Mn -
9 MindWalk Holdings 65.34 Mn 28.99 Mn 1.61 Mn 12,909.62
10 Natural Alternatives International 6.69 Mn -21.39 Mn 1.73 Mn 20,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 1.03 Mn
Mar 28, 2026 1.03 Mn
Dec 27, 2025 1.02 Mn
Sep 27, 2025 1.42 Mn
Jun 28, 2025 1.10 Mn
Mar 29, 2025 1.40 Mn
Dec 28, 2024 1.84 Mn
Sep 28, 2024 1.53 Mn
Jun 29, 2024 3.01 Mn
Mar 30, 2024 2.20 Mn
Dec 30, 2023 1.59 Mn
Sep 30, 2023 1.37 Mn
Jul 1, 2023 1.43 Mn
Apr 1, 2023 806,000.00
Dec 31, 2022 343,000.00
Sep 24, 2022 122,000.00
Jun 25, 2022 188,000.00
Mar 26, 2022 127,000.00
Dec 25, 2021 309,000.00
Sep 25, 2021 137,000.00
API Access

Charles River Laboratories International Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CRL&period=max&api_key=YOUR_API_KEY